Literature DB >> 2471112

Kynurenic acid inhibits the activation of kainic and N-methyl-D-aspartic acid-sensitive ionotropic receptors by a different mechanism.

M Bertolino1, S Vicini, E Costa.   

Abstract

The action of kynurenic acid on currents elicited by the activation of amino acid receptors was investigated in primary cultures of cortical neurons prepared from neonatal rats. Kynurenic acid was tested on currents elicited by both N-methyl-D-aspartic acid (NMDA) and kainate, using patch-clamp recording techniques in "outside-out" and "whole-cell" configurations. The inhibition by kynurenic acid was compared with that elicited by amino-phosphono-valeric acid (APV). Whole-cell currents, elicited by increasing doses of NMDA, were antagonized competitively by APV and non-competitively by kynurenic acid (ID50 70 microM); in contrast, kynurenic acid inhibited competitively the whole-cell currents elicited by kainic acid (ID50 500 microM). The non-competitive inhibition by kynurenic acid of the whole cell currents elicited by NMDA was antagonized competitively by glycine, a specific positive allosteric modulator of NMDA receptors; on the other hand glycine failed to change the inhibition by APV of the NMDA-elicited responses. Thus, kynurenic acid inhibits NMDA receptors allosterically (non-competitively) and kainic acid receptors isosterically (competitively).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471112     DOI: 10.1016/0028-3908(89)90078-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

Review 1.  Where does a migraine attack originate? In the brainstem.

Authors:  J Tajti; D Szok; Á Párdutz; B Tuka; A Csáti; A Kuris; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

2.  Calcium is involved in the R Mc1 (blb)-mediated hypersensitive response against Meloidogyne chitwoodi in potato.

Authors:  Laura J Davies; Charles R Brown; Axel A Elling
Journal:  Plant Cell Rep       Date:  2014-10-16       Impact factor: 4.570

Review 3.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

4.  Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys.

Authors:  Maria E Secci; Alessia Auber; Leigh V Panlilio; Godfrey H Redhi; Eric B Thorndike; Charles W Schindler; Robert Schwarcz; Steven R Goldberg; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-01-31       Impact factor: 7.853

5.  Excitatory amino acid receptor-stimulated phosphoinositide turnover in primary cerebrocortical cultures.

Authors:  G J Birrell; F W Marcoux
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

6.  Effects of antagonists on quisqualate and nicotinic receptor-mediated currents of midbrain neurones in culture.

Authors:  M Bijak; W Jarolimek; U Misgeld
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

7.  Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons.

Authors:  L K Nilsson; K R Linderholm; S Erhardt
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.850

8.  Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives.

Authors:  Annamária Fejes; Arpád Párdutz; József Toldi; László Vécsei
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 9.  The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.

Authors:  Tamera D Hughes; Osman F Güner; Emma Carine Iradukunda; Robert S Phillips; J Phillip Bowen
Journal:  Molecules       Date:  2022-01-02       Impact factor: 4.411

Review 10.  Kynurenic Acid Acts as a Signaling Molecule Regulating Energy Expenditure and Is Closely Associated With Metabolic Diseases.

Authors:  Delong Zhen; Junjun Liu; Xu Dong Zhang; Zehua Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.